ConductScience.org, home

Paper10437367

[Alpha 1-protease inhibitor deficiency. Diagnosis, follow-up and therapy options].

Köhnlein T and 2 others. Med Klin (Munich), 1999. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. [Alpha 1-protease inhibitor deficiency. Diagnosis, follow-up and therapy options]. Papers, record 10437367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10437367

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
[Alpha 1-protease inhibitor deficiency. Diagnosis, follow-up and therapy options].
PubMed
Journal
Med Klin (Munich)
PubMed
Year
1999
PubMed
Publication types
English Abstract, Journal Article, Review
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.07
iCite
Revised in PubMed
2019-11-11
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Köhnlein TT
2Klein HH
3Welte TT

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
alpha 1-Antitrypsin DeficiencyMajor topic
Adult
Female
Follow-Up Studies
Humans
Lung Diseases, Obstructive
Male
Middle Aged
Phenotype
Pulmonary Emphysema
alpha 1-Antitrypsin

Source PubMed

Download CSV of topics

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19157439[Proteinase/antiproteinase balance in patients with cystic fibrosis].Pneumologie1996https://conductscience.org/library/papers/9157439PubMed
22191843[Long-term substitution in homozygous alpha 1-antitrypsin deficiency. Effect of the proteinase-antiproteinase equilibrium in plasma and sputum].Dtsch Med Wochenschr1990https://conductscience.org/library/papers/2191843PubMed
38181327Replacement therapy for hereditary alpha1-antitrypsin deficiency. A program for long-term administration.Chest1994https://conductscience.org/library/papers/8181327PubMed
49552014The value of antibiotics and the outcomes of antibiotic therapy in exacerbations of COPD.Chest1998https://conductscience.org/library/papers/9552014PubMed
57784713Preliminary evidence that augmentation therapy diminishes degradation of cross-linked elastin in alpha-1-antitrypsin-deficient humans.Respiration1995https://conductscience.org/library/papers/7784713PubMed
69387938Alpha-1-antitrypsin replacement therapy: will its efficacy ever be proved?Eur Respir J1997https://conductscience.org/library/papers/9387938PubMed
73494198Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema.N Engl J Med1987https://conductscience.org/library/papers/3494198PubMed
87489808Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force.Eur Respir J1995https://conductscience.org/library/papers/7489808PubMed
99655709Lung volume reduction surgery has variable effects on blood gases in patients with emphysema.Am J Respir Crit Care Med1998https://conductscience.org/library/papers/9655709PubMed
103492164Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.Ann Intern Med1987https://conductscience.org/library/papers/3492164PubMed
119556728[Acute dyspnea].Internist (Berl)1998https://conductscience.org/library/papers/9556728PubMed
129387950
Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group.
Eur Respir J1997https://conductscience.org/library/papers/9387950PubMed
139655706Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group.Am J Respir Crit Care Med1998https://conductscience.org/library/papers/9655706PubMed
143493719
Comparison of alpha-1-antitrypsin levels and antineutrophil elastase capacity of blood and lung in a patient with the alpha-1-antitrypsin phenotype null-null before and during alpha-1-antitrypsin augmentation therapy.
Am Rev Respir Dis1987https://conductscience.org/library/papers/3493719PubMed
158694645The current status of lung volume reduction operations for emphysema.Ann Thorac Surg1996https://conductscience.org/library/papers/8694645PubMed
16316188Cigarette smoking induces functional antiprotease deficiency in the lower respiratory tract of humans.Science1979https://conductscience.org/library/papers/316188PubMed
177907437What role for theophylline?Thorax1994https://conductscience.org/library/papers/7907437PubMed
183485248Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency.N Engl J Med1986https://conductscience.org/library/papers/3485248PubMed
191083485Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants.N Engl J Med1976https://conductscience.org/library/papers/1083485PubMed
202787611Anti-neutrophil-elastase defenses of the lower respiratory tract in alpha 1-antitrypsin deficiency directly augmented with an aerosol of alpha 1-antitrypsin.Ann Intern Med1989https://conductscience.org/library/papers/2787611PubMed

See all 39 referencesDownload CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SERPINA15265PubTator's text mininghttps://conductscience.org/library/genes/5265

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10437367

GET https://conductscience.org/api/papers/v1/10437367/references?page=2